Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Motor Activity 1Leukemia, Myeloid, Acute 1Fatigue 1Breast Cancer With Chronic Lymphedema 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Waiting Lists × Clear all
NCT01706081 2019-08-29

Acupuncture for Chronic Lymphedema

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
82 enrolled 10 charts
Breast

Breast Cancer With Chronic Lymphedema

NCT00764231 2012-02-08

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Toronto Rehabilitation Institute

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Fatigue, Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡